Meta Pixel

News and Announcements

The Hydroponics Company Completes Placement at $8 million & Increases Share Price by 136.1%

  • Published January 11, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • The Hydroponics Company (ASX: THC or Company) advises that it has completed an $8m share placement to expand both its’ Canadian and Australian businesses.
  • THC confirms that the placement was fully subscribed with funds raised from both sophisticated and institutional investors. Notably, 7 new institutional investors to join the register.
  • The Placement was conducted at an issue price of $0.63 a share, representing a 19.8% discount to THC’s 5 day VWAP (5 – 11 December 2017).
  • The Hydroponics Company has experienced share price growth of 136.1%.

To read the full article on the ASX please click here.

 

About Canndeo Ltd

Canndeo is an Australian based, internationally linked and vertically integrated medicinal cannabis company.

Request Information

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now